首页> 外文会议>Chinese international peptide symposium >Study on Anticancer Mechanism of Cyclic Tetrapeptide HDACIs
【24h】

Study on Anticancer Mechanism of Cyclic Tetrapeptide HDACIs

机译:环三肽HDACIS的抗癌机制研究

获取原文

摘要

@@ Reversible acetylation and deacetylation of ε-amino group of lysine residues on histone tails by histone acetyl transferase (HAT) and histone deacetylase (HDACs) enzymes play a crucial role in the epigenetic regulation of gene expression by changing the chromatin architecture and transcriptional activity[1]. HDACs can cause high histone deacetylation, lead to cancer developments including the control of cell cycle arrest, differentiation and apoptosis. HDAC inhibitors (HDACIs) have the potential of prevention proliferation of cancer, and emerged as an attractive target as anticancer drugs[2]. Cyclic peptides are one of the most important class of HDACIs.
机译:通过组蛋白乙酰转移酶(帽子)和组蛋白脱乙酰化酶(HDACs)酶在组蛋白尾部的ε-氨基的ε-氨基的ε-氨基的ε-氨基的脱乙酰化在基因表达的表观遗传调节中,通过改变染色质架构和转录活性起到至关重要的作用[1]。 HDAC可引起高层脱乙酰化,导致癌症发育,包括控制细胞周期停滞,分化和细胞凋亡。 HDAC抑制剂(HDACIS)具有预防癌症的潜力,并成为抗癌药物的有吸引力的目标[2]。循环肽是最重要的HDACI之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号